Health economics provides a framework for evaluating the allocation of limited resources in healthcare, ensuring that interventions not only deliver clinical benefit but also represent optimal use of ...
Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial The economic evaluation, conducted from societal ...
Atezolizumab With Bevacizumab and Nonplatinum Chemotherapy for Recurrent Ovarian Cancer: Final Results From the Placebo-Controlled AGO-OVAR 2.29/ENGOT-ov34 Phase III Trial For the model, we used ...
Utility measurement has emerged as a cornerstone in assessing health outcomes, providing a quantitative basis for comparing diverse health states through standardised metrics such as quality‐adjusted ...
Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III EXPLORER-HCM trial has demonstrated that the novel cardiac myosin inhibitor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results